Therapeutic Asset Ratings
1,133 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Personalized Neoantigen Tumor Vaccine
Cancer
Ruijin Hospital
Early P1
C
(33)
Prochlorperazine
Plasma Cell Myeloma
Koen van Besien
Early P1
C
(33)
R130
Breast Cancer
Shanghai Yunying Medical Technology
Early P1
C
(33)
R130
Colorectal Cancer
Shanghai Yunying Medical Technology
Early P1
C
(33)
R130
Ovarian Cancer
Shanghai Yunying Medical Technology
Early P1
C
(33)
R130
Pancreatic Neoplasm
Shanghai Yunying Medical Technology
Early P1
C
(33)
rd133
Neoplasm
The First Affiliated Hospital with Nanjing Medical University
Early P1
C
(33)
rd14-01 cell
Neoplasm
Shen Lin
Early P1
C
(33)
Recombinant L-Ifn Adenovirus
Breast Cancer
Shanghai Fengxian District Central Hospital
Early P1
C
(33)
Rilvegostomig
Neoplasm
Presage Biosciences
Early P1
C
(33)
rn1101
Plasma Cell Myeloma
YANRU WANG
Early P1
C
(33)
ROCK2 INHIBITOR KD025
Neoplasm
jianming xu
Early P1
C
(33)
Sabestomig
Neoplasm
Presage Biosciences
Early P1
C
(33)
Saprna™-Mica/B Tumor Vaccine
Cancer
NING LI
Early P1
C
(33)
Semaglutide
Colorectal Cancer
University of Arizona
Early P1
C
(33)
Semaglutide
Pancreatic Neoplasm
University of Arizona
Early P1
C
(33)
Senl103
Plasma Cell Myeloma
Hebei Senlang Biotechnology Inc., Ltd.
Early P1
C
(33)
Sj-Neo006
Pancreatic Neoplasm
Jinling Hospital, China
Early P1
C
(33)
SOMATOSTATIN
Obesity Disorder
University of Copenhagen
Early P1
C
(33)
Tazverik
Prostate Cancer
Edwin Posadas, MD
Early P1
C
(33)
TIL
Cancer
Shanghai Juncell Therapeutics
Early P1
C
(33)
Tirzepatide
Prostate Cancer
M.D. Anderson Cancer Center
Early P1
C
(33)
VGT-309
Colorectal Cancer
Stephan Rogalla
Early P1
C
(33)
VITAMIN D
Plasma Cell Myeloma
Amany Keruakous, MD, MS.
Early P1
C
(33)
Volrustomig
Neoplasm
Presage Biosciences
Early P1
C
(33)
Showing 1026 to 1050 of 1,133 assets
Previous
Page 42 of 46
Next
